Literature DB >> 4764425

Properties of the Michaelis-Menten equation and its integrated form which are useful in pharmacokinetics.

J G Wagner.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4764425     DOI： 10.1007/bf01059625

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  13 in total

1.  The kinetics of alcohol elimination in man.

Authors:  F LUNDQUIST; H WOLTHERS
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1958

2.  The role of the hepatic microsomal ethanol oxidizing system (MEOS) for ethanol metabolism in vivo.

Authors:  C S Lieber; L M DeCarli
Journal:  J Pharmacol Exp Ther       Date:  1972-05       Impact factor: 4.030

3.  Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation.

Authors:  N Gerber; J G Wagner
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1972-05

4.  Genetic and environmental factors affecting ethanol metabolism in man.

Authors:  E S Vesell; J G Page; G T Passananti
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

5.  Thiopental pharmacokinetics.

Authors:  K B Bischoff; R L Dedrick
Journal:  J Pharm Sci       Date:  1968-08       Impact factor: 3.534

6.  Nonlinear dose-concentration relationships.

Authors:  E Krüger-Thiemer
Journal:  Farmaco Sci       Date:  1968-08

7.  Saturation of alcohol dehydrogenase by ethanol.

Authors:  A Goldstein
Journal:  N Engl J Med       Date:  1970-10-15       Impact factor: 91.245

8.  Studies on the metabolism of diphenylhydantoin in mice.

Authors:  N Gerber; K Arnold
Journal:  J Pharmacol Exp Ther       Date:  1969-05       Impact factor: 4.030

9.  The solution of pharmacological problems with computers. 8. Non first-order models of drug metabolism.

Authors:  E Krüger-Thiemer; R R Levine
Journal:  Arzneimittelforschung       Date:  1968-12

10.  Pharmacokinetics of salicylate elimination in man.

Authors:  G Levy
Journal:  J Pharm Sci       Date:  1965-07       Impact factor: 3.534
View more
  35 in total

1.  Confidence interval criteria for assessment of dose proportionality.

Authors:  B P Smith; F R Vandenhende; K A DeSante; N A Farid; P A Welch; J T Callaghan; S T Forgue
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

2.  Do you need a pharmacokinetic model, and, if so, which one?

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

3.  Area-dose relationships in nonlinear models.

Authors:  N P Chau
Journal:  J Pharmacokinet Biopharm       Date:  1976-12

4.  A tracer interaction method for nonlinear pharmacokinetics analysis: application to evaluation of nonlinear elimination.

Authors:  P Veng-Pedersen; J A Widness; J Wang; R L Schmidt
Journal:  J Pharmacokinet Biopharm       Date:  1997-10

5.  Pharmacokinetics of ethanol after oral administration in the fasting state.

Authors:  P K Wilkinson; A J Sedman; E Sakmar; D R Kay; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1977-06

6.  Back calculation of blood alcohol concentration.

Authors:  K O Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-03

7.  Saturable rate of cefatrizine absorption after oral administration to humans.

Authors:  B G Reigner; W Couet; J P Guedes; J B Fourtillan; T N Tozer
Journal:  J Pharmacokinet Biopharm       Date:  1990-02

8.  Application of moment analysis to nonlinear drug disposition described by the Michaelis-Menten equation.

Authors:  A T Chow; W J Jusko
Journal:  Pharm Res       Date:  1987-02       Impact factor: 4.200

9.  Calculations and application of mean residence times for drugs which demonstrate one-compartment distribution and Michaelis-Menten elimination.

Authors:  J A Cook; P R Gwilt
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

10.  Pharmacokinetics and pharmacodynamics of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione in patients with postmenopausal breast cancer.

Authors:  B P Haynes; M Jarman; M Dowsett; A Mehta; P E Lønning; L J Griggs; A Jones; T Powles; R Stein; R C Coombes
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.